Chromatrap® 96: A New Solid-State Platform for High-Throughput ChIP

In this application note, a new enriched assay process for profiling simultaneous protein and DNA patterns that characterize disease mechanisms is presented using the Chromatrap® 96 (C96). The high-throughput, patented solid-state platform enables 96 simultaneous assays across a multitude of target proteins, cell-signaling mechanisms, cell types and/or patient samples in one day. Chromatrap® offers a step change in ChIP productivity that significantly improves the efficiency and scope of epigenetic research.